BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21809408)

  • 1. Medicine safety: experiences and perceptions of the general public in Liverpool.
    Krska J; Jones L; McKinney J; Wilson C
    Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1098-103. PubMed ID: 21809408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reporting natural health product related adverse drug reactions: is it the pharmacist's responsibility?
    Walji R; Boon H; Barnes J; Welsh S; Austin Z; Baker GR
    Int J Pharm Pract; 2011 Dec; 19(6):383-91. PubMed ID: 22060233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse drug reactions in patients in an Iranian department of internal medicine.
    Pourseyed S; Fattahi F; Pourpak Z; Gholami K; Shariatpanahi SS; Moin A; Kazemnejad A; Moin M
    Pharmacoepidemiol Drug Saf; 2009 Feb; 18(2):104-10. PubMed ID: 19101919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse drug reaction reporting by general medical practitioners and retail pharmacists in Harare--a pilot study.
    Ball D; Tisócki T
    Cent Afr J Med; 1998 Aug; 44(8):190-5. PubMed ID: 10101417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Societal perspectives on over-the-counter (OTC) medicines.
    Wazaify M; Shields E; Hughes CM; McElnay JC
    Fam Pract; 2005 Apr; 22(2):170-6. PubMed ID: 15710640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient reporting of adverse drug reactions: useful information for pain management?
    Jarernsiripornkul N; Krska J; Richards RM; Capps PA
    Eur J Pain; 2003; 7(3):219-24. PubMed ID: 12725844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting.
    Matos C; van Hunsel F; Joaquim J
    Eur J Clin Pharmacol; 2015 Jul; 71(7):883-90. PubMed ID: 26004569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacovigilance amongst patent medicine vendors (PMVs) in Ekiti state, Nigeria.
    Awodele O; Adeniran A; Awodele DF
    Int J Risk Saf Med; 2012; 24(2):65-72. PubMed ID: 22751188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public confidence in ADR identification and their views on ADRreporting: mixed methods study.
    Jarernsiripornkul N; Patsuree A; Krska J
    Eur J Clin Pharmacol; 2017 Feb; 73(2):223-231. PubMed ID: 27837337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Patterns of drug consumption and the occurrence of adverse drug reactions among students of public health].
    Plichta D; Doryńska A; Spiewak R
    Pol Merkur Lekarski; 2012 Apr; 32(190):232-7. PubMed ID: 22708280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different standards for reporting ADRs to herbal remedies and conventional OTC medicines: face-to-face interviews with 515 users of herbal remedies.
    Barnes J; Mills SY; Abbot NC; Willoughby M; Ernst E
    Br J Clin Pharmacol; 1998 May; 45(5):496-500. PubMed ID: 9643624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lay public's explicit and implicit definitions of drugs.
    Björnsdóttir I; Almarsdóttir AB; Traulsen JM
    Res Social Adm Pharm; 2009 Mar; 5(1):40-50. PubMed ID: 19285288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance of suspected adverse reactions to natural health products in Italy.
    Menniti-Ippolito F; Mazzanti G; Santuccio C; Moro PA; Calapai G; Firenzuoli F; Valeri A; Raschetti R
    Pharmacoepidemiol Drug Saf; 2008 Jun; 17(6):626-35. PubMed ID: 18327867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public perspectives on consent for the linkage of data to evaluate vaccine safety.
    Berry JG; Gold MS; Ryan P; Duszynski KM; Braunack-Mayer AJ;
    Vaccine; 2012 Jun; 30(28):4167-74. PubMed ID: 22546331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China.
    Su C; Ji H; Su Y
    Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):217-22. PubMed ID: 20033911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-the-counter medicine use prior to and during hospitalization.
    Oborne CA; Luzac ML
    Ann Pharmacother; 2005 Feb; 39(2):268-73. PubMed ID: 15644485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-medication with over-the-counter and prescribed drugs causing adverse-drug-reaction-related hospital admissions: results of a prospective, long-term multi-centre study.
    Schmiedl S; Rottenkolber M; Hasford J; Rottenkolber D; Farker K; Drewelow B; Hippius M; Saljé K; Thürmann P
    Drug Saf; 2014 Apr; 37(4):225-35. PubMed ID: 24550104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nationwide survey of subjectively reported adverse drug reactions in Sweden.
    Isacson D; Johansson L; Bingefors K
    Ann Pharmacother; 2008 Mar; 42(3):347-53. PubMed ID: 18303136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients' use of information about medicine side effects in relation to experiences of suspected adverse drug reactions: a cross-sectional survey in medical in-patients.
    Krska J; Morecroft CW
    Drug Saf; 2013 Aug; 36(8):673-80. PubMed ID: 23700262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low awareness of adverse drug reaction reporting systems: a consumer survey.
    Robertson J; Newby DA
    Med J Aust; 2013 Nov; 199(10):684-6. PubMed ID: 24237099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.